Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Large Growth in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 19,700 shares, an increase of 1,213.3% from the September 15th total of 1,500 shares. Based on an average daily trading volume, of 4,800 shares, the short-interest ratio is currently 4.1 days.

Cardio Diagnostics Stock Up 14.3 %

Shares of Cardio Diagnostics stock traded up $0.01 during trading on Friday, hitting $0.04. 23,055 shares of the stock were exchanged, compared to its average volume of 16,064. The company has a fifty day moving average price of $0.04 and a 200-day moving average price of $0.05. Cardio Diagnostics has a 1-year low of $0.02 and a 1-year high of $0.28.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.